ABBV

Ichnos Glenmark Innovation (IGI) Announces New Development Candidate, ISB 2301, a First-in-Class Multispecific Immune Cells Activator Targeting Solid Tumors

05/20 07:00 am

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

05/19 01:00 pm

2 Stocks That Are Much Cheaper Than They Look

05/19 09:30 am

2 High-Yield Healthcare Stocks to Buy Before They Raise Payouts

05/19 06:30 am

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

05/11 05:15 pm

Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape | DelveInsight

05/11 01:00 pm

What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress

05/10 01:37 pm

Want Reliable Dividend Income in May? These 2 Stocks Deliver

05/06 04:10 am

Want to Collect a High Dividend Every Month? Invest in These 3 Stocks

05/05 12:30 pm

AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook

05/04 04:30 pm

3 of the Best Dividend Stocks to Buy in May 2026

05/04 04:26 pm

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026

05/01 02:36 am

AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

04/30 03:00 pm

AbbVie et adMare BioInnovations nomment RIME Therapeutics lauréat du Prix AbbVie des innovateurs en biotechnologies au Québec

04/30 03:00 pm

AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength

04/29 02:49 pm

Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape

04/28 01:00 pm

AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug

04/24 08:46 am

Mental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

04/24 04:57 am

Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

04/21 04:34 am

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

04/20 02:30 am

The Psychedelic Revolution in Mental Healthcare

04/17 04:19 pm

Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

04/16 01:00 pm

3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market

04/15 11:15 am

Eli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients

04/13 09:29 am

S&P 500 Index Dividend Yields Are Teasing All-Time Lows. Here Are 3 Dividend Darlings That Crush This Trend.

04/13 06:24 am

3 Companies Aggressively Raising Dividends While Others Play Defense

04/10 03:17 pm

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments

04/10 04:59 am

Atopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline

04/10 04:52 am

Atopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

04/10 04:46 am

Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

04/10 04:43 am

Could Buying This Dividend Pharma Stock Today Set You Up for Life?

04/09 08:15 pm

3 Dividend Aristocrats Whose Yields Can Help Combat Inflation

04/09 04:10 pm

This Investor's $5 Million ETF Buy Pushes 2028 Bond Fund to Nearly 4% of AUM

04/09 09:32 am

This Fund's Ladder Strategy Expanded With a $4 Million Buy in One 2027 Bond ETF

04/09 08:33 am

Red Spruce Adds $3.35 Million to a 2029 Bond ETF With 4.5% Yield. Here's What Investors Should Know

04/09 08:24 am

This Pharma Dividend Has Been Raised Every Single Year for Over a Decade

04/07 09:30 pm

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

04/06 01:20 pm

The Best Dividend ETF to Buy in April 2026 If You Want Passive Income

04/05 09:22 am

2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory

04/02 05:32 pm

The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight

04/02 01:00 pm

Merck Just Made a Big Bet on a New Cancer Growth Engine

04/02 11:32 am

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

04/01 01:00 pm

This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

03/30 06:30 am

Bile Duct Cancer Market to Grow by $1.07 Billion During 2026-2030: Key Trends, Investment Opportunities and Competitive Strategies Analyzed

03/30 06:00 am

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.

03/24 07:06 am

Why AbbVie Stock Looks Like a Dirt Cheap Buy Right Now

03/23 02:30 pm

The Smartest Dividend ETF to Buy With $1,000 Right Now

03/20 11:30 am

Best Healthcare Stocks to Buy After the Market Pullback

03/20 07:15 am

2 Healthcare Stocks to Buy Before They Get Bought Out

03/20 05:34 am

Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

03/19 08:25 am